1. Tumor microenvironment of adult T-cell leukemia/lymphoma
   Mai Takeuchi et al, 2021, Journal of Clinical and Experimental Hematopathology CrossRef
2. Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
   Muming Yu et al, 2017, Molecular Medicine Reports CrossRef
3. Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma
   Yang Zhao et al, 2022, Frontiers in Genetics CrossRef
4. Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy
   Kun Li et al, 2024, Frontiers in Immunology CrossRef
5. The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma
   Benjamin J. Chen et al, 2019, Oncotarget CrossRef
6. Elevated Expression of T-Cell Immunoglobulin and Mucin Domain 3 on T Cells from Peripheral Blood in Patients with Cervical Carcinoma
   Juan Li et al, 2021, Gynecologic and Obstetric Investigation CrossRef
7. Prognostic and clinicopathological value of high expression of TIM‐3 in different cancer types: A meta‐analysis
   Wenbo Xu et al, 2020, Precision Medical Sciences CrossRef
8. Can we use epigenetics to prime chemoresistant lymphomas?
   Jennifer E. Amengual, 2020, Hematology CrossRef
9. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion
   Cansu Yıldırım, 2024, Molecular Biology Reports CrossRef
10. Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential
    Reem Saleh et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
11. Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma
    Yoshihiro Komohara et al, 2018, Journal of Clinical and Experimental Hematopathology CrossRef
12. Immune-Checkpoint Blockade Therapy in Lymphoma
    Ayumi Kuzume et al, 2020, International Journal of Molecular Sciences CrossRef
13. Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
    Zuzana Kocibalova et al, 2021, Cancers CrossRef
14. TIM-3 in Leukemia; Immune Response and Beyond
    Mahnaz Rezaei et al, 2021, Frontiers in Oncology CrossRef
15. B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?
    Minodora Desmirean et al, 2020, Journal of Clinical Medicine CrossRef
16. The Expression and Clinical Significance of CD4+Tim-3+T Cell in Peripheral Blood for Acute Henoch Schonlein Purpura Patients
    宵霖 李, 2018, Advances in Clinical Medicine CrossRef
17. Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages.
    Yoshihiro Komohara et al, 2017, Journal of Clinical and Experimental Hematopathology CrossRef
18. TIM‐3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways
    Yoshikane Kikushige, 2021, Cancer Science CrossRef